Page last updated: 2024-10-31

metoclopramide and Anemia, Hypochromic

metoclopramide has been researched along with Anemia, Hypochromic in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Anemia, Hypochromic: Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farthmann, EH1
Fritsch, WP1

Other Studies

1 other study available for metoclopramide and Anemia, Hypochromic

ArticleYear
[Conditions after total gastrectomy].
    Zeitschrift fur Gastroenterologie. Verhandlungsband, 1982, Volume: 17

    Topics: Adenocarcinoma; Anemia, Hypochromic; Antacids; Cholestyramine Resin; Dumping Syndrome; Esophagitis,

1982